Literature DB >> 7960032

Microglial tyrosine phosphorylation systems in normal and degenerating brain.

H L Karp1, M L Tillotson, J Soria, C Reich, J G Wood.   

Abstract

Phosphotyrosine and protein tyrosine phosphatase antibodies have been used to assess the distribution and potential functions of tyrosine phosphorylation systems in normal brain and cell cultures, as well as in a model of neural degeneration. Western blot and immunohistochemical analysis showed that a panel of antiphosphotyrosine antibodies recognizing different tyrosine phosphorylated substrates all selectively labeled ramified microglia in sections of brain tissue. This significantly extends our previous observation (GLIA 2:412-419, 1989) that a single, limited, phosphotyrosine antibody served as a histological marker for microglia. The present results show that tyrosine phosphorylation of a variety of substrates is quantitatively enriched in microglia compared to other neural cell types. We also show that the protein tyrosine phosphatase, CD45, is constitutively expressed by ramified microglia in vivo and by ameboid microglia in vitro. Thus, the major enzymes constituting tyrosine phosphorylation systems are present in normal microglia. Neuronal degeneration in the trigeminal nucleus, caused by introduction of the neurotoxic lectin, ricin, into the peripheral nerve is accompanied by a robust upregulation of phosphotyrosine signal in ramified microglial adjacent to the nucleus and in ameboid microglia in the degenerating nucleus. The presence of phosphotyrosine in ramified microglia is consistent with a role for tyrosine phosphorylation systems in the activation of microglia and in the signaling events accompanying conversion of resting microglia to the ameboid form.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7960032     DOI: 10.1002/glia.440110310

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  10 in total

1.  CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase.

Authors:  J Tan; T Town; T Mori; Y Wu; M Saxe; F Crawford; M Mullan
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  A novel role for protein tyrosine phosphatase shp1 in controlling glial activation in the normal and injured nervous system.

Authors:  A Horvat; F Schwaiger; G Hager; F Brocker; R Streif; P Knyazev; A Ullrich; G W Kreutzberg
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

3.  Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation.

Authors:  R Wada; C J Tifft; R L Proia
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

4.  Cerebral ischemia and seizures induce tyrosine phosphorylation of PYK2 in neurons and microglial cells.

Authors:  D Tian; V Litvak; S Lev
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

5.  Microglial response to amyloid plaques in APPsw transgenic mice.

Authors:  S A Frautschy; F Yang; M Irrizarry; B Hyman; T C Saido; K Hsiao; G M Cole
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

6.  Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer's disease.

Authors:  Gunjan Dhawan; Colin K Combs
Journal:  J Neuroinflammation       Date:  2012-07-02       Impact factor: 8.322

7.  Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD.

Authors:  Carol A Colton; Ryan T Mott; Hayley Sharpe; Qing Xu; William E Van Nostrand; Michael P Vitek
Journal:  J Neuroinflammation       Date:  2006-09-27       Impact factor: 8.322

8.  CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation.

Authors:  Yuyan Zhu; Huayan Hou; William V Nikolic; Jared Ehrhart; Elona Rrapo; Paula Bickford; Brian Giunta; Jun Tan
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

9.  Characterization of Novel Src Family Kinase Inhibitors to Attenuate Microgliosis.

Authors:  Gunjan D Manocha; Kendra L Puig; Susan A Austin; Kathleen Seyb; Marcie A Glicksman; Colin K Combs
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

10.  Neuregulin upregulates microglial α7 nicotinic acetylcholine receptor expression in immortalized cell lines: implications for regulating neuroinflammation.

Authors:  Malwina Mencel; Michelle Nash; Christian Jacobson
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.